Abstract:Background: The successful application of randomized, double-blind placebo-controlled studies requires maximum blinding. Organoleptic properties of the placebo should be similar to the drug, making it difficult to distinguish between the two. The uniqueness of traditional Chinese medicine (TCM) preparations makes it challenging to prepare placebo. Evaluation of the TCM placebo simulation effect can determine whether the preparation of placebo can be genuinely blind in clinical trials. There is still a lack of well-established methods to evaluate TCM placebos. Hence, this study aimed to explore the evaluation methodology of TCM placebo simulation. Methods: An independent evaluation method and three comparative evaluation methods were proposed, and three dosage forms (oral liquid, capsule, and granule) were tested. The independent evaluation, in which each person was given an experimental drug or a placebo, gave an overall assessment of organoleptic properties in a blind state. We comparatively evaluated the similarity in organoleptic properties between the experimental drug and placebo. According to different distribution methods, we divided comparative evaluation methods into three. In method 1, the evaluator was given the experimental drug and placebo and was told that there must be a placebo among them. In method 2, each evaluator was randomly assigned to the combination group or two investigational drugs group. In method 3, the evaluator was assigned to a set of three coded samples, numbered by random three-digit numbers, each different, two of which were identical, and the two samples were equally frequent. Results: In the independent evaluation, there was no difference between TCM placebo and experimental drugs in a blind state at the level of p = 0.05. Even though the comparative evaluation methods enabled identification of potential differences between the two samples, methods 2 and 3 were better than method 1 in eliminating psychological factors. Also, in method 3, the completely random method combined with the blind method eliminated the subjectivity and objectivity bias and improved the experiment’s credibility compared with the previous two methods. Conclusion: Regardless of the methods that could evaluate the placebo’s simulated effect in actual clinical trials, we suggest that independent evaluation and comparative evaluation (method 3) should be combined to reflect better whether the placebo is truly blind.

Ethical Review on Placebo Control in Ophthalmic New Drug Clinical Trials

A review of the ethical issues related to the use of placebo controls in conducting clinical trials

Developing Placebos for Clinical Research in Traditional Chinese Medicine: Assessing Organoleptic Properties of Three Dosage Forms (Oral Liquid, Capsule and Granule)

Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine

Study on the Standardization of Initial Ethical Review of Drug Clinical Trial

Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives

The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine

Placebo Control in the Design of Acupuncture Clinical Trials

Consideration of Several Problems in Clinical Application of Prostaglandin Analogues in Lowering Intraocular Pressure

Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol

Discussion on problems in conducting the clinical trials on off-label use of drug

Review on potential effects of traditional Chinese medicine on glaucoma

Review of current controversial issues in clinical trials

Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)

Focus on the Ethics Problem in Glaucoma Management

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline

A review of using Traditional Chinese Medicine in the management of glaucoma and cataract

Preserving the placebo effect after disclosure: A new perspective on non‐deceptive placebos

Assessment of the Reporting Quality of Placebo-controlled Randomized Trials on the Treatment of Type 2 Diabetes With Traditional Chinese Medicine in Mainland China: A PRISMA-Compliant Systematic Review.

Effect of Chinese herbal compounds on ocular fundus signs and vision in conventional treated-persons with non-proliferative diabetic retinopathy: A systematic review and meta-analysis

Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis